Page last updated: 2024-09-03

celastrol and Malignant Melanoma

celastrol has been researched along with Malignant Melanoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's4 (44.44)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Fang, Y; Jiang, W; Li, Z; Wang, R; Xie, C; Xie, S; Xie, X1
An, L; Cong, X; Jia, Y; Li, J; Xiao, C; Yang, H; Zhang, P1
Jiang, Y; Lazarovici, P; Li, S; Liao, R; Peng, T; Silva, M; Yan, F; Zheng, W1
Chen, Y; Gao, J; Hu, M; Huang, L; Liu, Q; Liu, Y; Qiu, N; Shen, L; Shen, Y; Zhou, X1
Pan, J; Zhang, B; Zhang, J1
Chen, F; Hou, L; Huang, L; Liu, Q; Shen, L; Wang, D; Zhang, X1
Chen, M; Doudican, N; Orlow, SJ; Osman, I; Rose, AE1
Lee, JH; Lee, MK; Park, KH; Seo, KI; Tachibana, H; Won, YS; Yamada, K1
Abbas, S; Bhoumik, A; Cosford, ND; Dahl, R; Krajewski, S; Ronai, ZA; Vasile, S1

Other Studies

9 other study(ies) available for celastrol and Malignant Melanoma

ArticleYear
Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin-like growth factor-1 receptor and its downstream pathways.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:11

    Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Humans; Melanoma; Molecular Docking Simulation; Pentacyclic Triterpenes; Phosphorylation; Receptor, IGF Type 1; Signal Transduction; Triterpenes; Uveal Neoplasms

2019
Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Animals; Antineoplastic Agents, Phytogenic; Delayed-Action Preparations; Dynamic Light Scattering; Hydrophobic and Hydrophilic Interactions; Male; Melanoma; Melanoma, Experimental; Mice, Inbred C57BL; Micelles; Microscopy, Electron, Transmission; Nanoparticles; Pentacyclic Triterpenes; Polyethylene Glycols; Polylysine; Triterpenes

2020
Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:11

    Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Nucleus; Forkhead Box Protein O3; Humans; Melanoma; Neoplasm Invasiveness; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Uveal Neoplasms

2020
Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy.
    Biomaterials, 2021, Volume: 269

    Topics: Animals; B7-H1 Antigen; Humans; Immunotherapy; Melanoma; Mice; Pentacyclic Triterpenes; Tumor Microenvironment

2021
Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF‑κB pathway.
    International journal of oncology, 2017, Volume: 51, Issue:3

    Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Melanoma; Molecular Targeted Therapy; Neoplastic Stem Cells; NF-kappa B; NF-KappaB Inhibitor alpha; Pentacyclic Triterpenes; Signal Transduction; Transcription Factor RelA; Triterpenes; Tumor Necrosis Factor-alpha; Uveal Neoplasms; Vinblastine

2017
Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma.
    ACS nano, 2018, 08-28, Volume: 12, Issue:8

    Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Immunosenescence; Immunotherapy; Melanoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitoxantrone; Nanoparticles; NIH 3T3 Cells; Pentacyclic Triterpenes; Skin Neoplasms; Triterpenes; Tumor Microenvironment

2018
Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells.
    Molecular cancer research : MCR, 2009, Volume: 7, Issue:12

    Topics: Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Gene Knockdown Techniques; Humans; I-kappa B Proteins; Inhibitory Concentration 50; Melanoma; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Pentacyclic Triterpenes; Phosphorylation; Proteasome Endopeptidase Complex; Protein Transport; RNA, Small Interfering; Temozolomide; Triterpenes; Tumor Necrosis Factor-alpha; Ubiquitinated Proteins

2009
Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling.
    Apoptosis : an international journal on programmed cell death, 2012, Volume: 17, Issue:12

    Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Melanoma; Mitochondria; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; Triterpenes

2012
Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Nov-15, Volume: 13, Issue:22 Pt 1

    Topics: Activating Transcription Factor 2; Animals; Cell Line, Tumor; Chromones; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; MAP Kinase Kinase 4; Melanoma; Mice; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-jun; Skin Neoplasms; Small Molecule Libraries; Transcription, Genetic; Triterpenes

2007